Latest from Sylvester Comprehensive Cancer Center

Izidore S. Lossos, MD, discusses the current pillars of care and barriers in the treatment of patients with early-stage and advanced follicular lymphoma, as well as mantle cell lymphoma.

Stephen D. Nimer, MD, professor of medicine, director, Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses the use of chimeric antigen receptor (CAR) T-cell therapy in hematologic malignancies.

Izidore S. Lossos, MD, professor, director, Lymphoma Program Head of hematological malignancies site disease group, Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses treatment approaches for patients with mantle cell lymphoma (MCL).

Joseph D. Rosenblatt, MD, professor, associate director for faculty development, University of Miami, Sylvester Comprehensive Cancer Center, discusses the phase III DUO trial in patients with relapsed/refractory chronic lymphocytic leukemia (CLL).

Lazaros John Lekakis, MD, associate professor of clinical medicine, University of Miami, Sylvester Comprehensive Cancer Center, discusses current research with chimeric antigen receptor (CAR) T-cell therapy across hematologic malignancies.

Mohammad Jahanzeb, MD, shares the challenges of real-world eligibility for immunotherapy in lung cancer and beyond.

Vivek Venkatramani, MD, and Dipen J. Parekh, MD, discuss the evolution of surgery in bladder cancer.

Frances Valdes-Albini, MD, assistant professor of clinical medicine, Sylvester Comprehensive Cancer Center, University of Miami Health System, discusses ongoing clinical trials of patients with HER2-positive breast cancer.